MFDS
- Status: likely_approved
🇰🇷 LONCASTUXIMAB TESIRINE in South Korea
LONCASTUXIMAB TESIRINE (LONCASTUXIMAB TESIRINE) regulatory status in South Korea.
Marketing authorisation
LONCASTUXIMAB TESIRINE in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in South Korea
Frequently asked questions
Is LONCASTUXIMAB TESIRINE approved in South Korea?
Yes. MFDS has authorised it.
Who is the marketing authorisation holder for LONCASTUXIMAB TESIRINE in South Korea?
Marketing authorisation holder not available in our data.